These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30607139)

  • 1. Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation.
    Yao S; Chen X; Chen J; Guan Y; Liu Y; Chen J; Lv X
    Cancer Cell Int; 2018; 18():213. PubMed ID: 30607139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells.
    Yao S; Wu D; Chen J; Wang P; Lv X; Huang J
    FEBS Open Bio; 2019 Apr; 9(4):605-617. PubMed ID: 30984536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer.
    Zhi X; Tao J; Zhang L; Tao R; Ma L; Qin J
    Cell Death Dis; 2016 Dec; 7(12):e2569. PubMed ID: 28032859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population.
    Ali A; Nimisha ; Sharma AK; Mishra PK; Saluja SS
    Mol Genet Genomics; 2023 Sep; 298(5):1087-1105. PubMed ID: 37289229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of speckle-type POZ protein for the prediction of poor prognosis in patients with non-small cell lung cancer.
    Li JJ; Zhang JF; Yao SM; Huang H; Zhang S; Zhao M; Huang JA
    Oncol Lett; 2017 Sep; 14(3):2743-2748. PubMed ID: 28927035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP.
    Gong H; Liu F; Liu X; Min S; Wu N; Liu X; Liu Y; Han S; Zhang Y; Zhang Y; Hu Y; Liu X; Wang X
    EBioMedicine; 2019 Jun; 44():138-149. PubMed ID: 31105033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
    Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
    Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
    Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
    Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the
    Tan X; Zhang S; Gao H; He W; Xu M; Wu Q; Ni X; Jiang H
    Oncol Lett; 2019 Aug; 18(2):1278-1286. PubMed ID: 31423188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
    Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
    Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.